This inventor holds 1 USPTO granted patent. Top assignee: Cellectis S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Philippe Duchateau: Innovator in Genetic Modification
Introduction
Philippe Duchateau is a prominent inventor based in Draveil, US. He has made significant contributions to the field of genetic engineering, particularly in the development of methods for modifying cells to deliver therapeutic proteins. His innovative work has the potential to impact various medical treatments and therapies.
Latest Patents
Philippe Duchateau holds a patent titled "Methods to Genetically Modify Cells for Delivery of Therapeutic Proteins." This patent represents a crucial advancement in the field, showcasing his expertise and dedication to improving healthcare solutions. He has 1 patent to his name, reflecting his commitment to innovation.
Career Highlights
Duchateau is currently employed at Cellectis S.A., a company known for its pioneering work in gene editing and cell therapy. His role at Cellectis allows him to collaborate with other leading experts in the field, further enhancing his contributions to genetic research.
Collaborations
Throughout his career, Philippe has worked alongside notable colleagues such as Alexandre Juillerat and Laurent Poirot. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their shared field of expertise.
Conclusion
Philippe Duchateau is a key figure in the realm of genetic modification, with a focus on therapeutic applications. His work at Cellectis and his patented methods highlight his dedication to advancing medical science. His contributions are paving the way for future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile